FindTrial
Sign In

Use of a Composite Score to Predict Outcomes in Patients with COPD Exacerbations

Role of Composite Score APACHE II ,CRP, D DIMER, PCO2 in Prognosticating Outcomes in COPD Exacerbations - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087177
Enrollment
200
Registered
2025-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J441- Chronic obstructive pulmonary disease with (acute) exacerbation

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

SANTINIKETAN MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than equals to 40 years Diagnosis of COPD confirmed by spirometry prior to admission Hospitalized with acute exacerbation of COPD Consent to participate

Exclusion criteria

Exclusion criteria: Coexistent severe sepsis/septic shock unrelated to COPD Known pulmonary embolism on admission Active malignancy End-stage organ failure like renal or liver or heart

Design outcomes

Primary

MeasureTime frame
Role of Composite Score comprising of APACHE II and CRP and D DIMER and PCO2 in predicting outcomes and in hospital mortality in patients admitted with acute exacerbation of COPDTimepoint: DURING ADMISSION AND UPTO 14 DAYS FROM ADMISSION OR UNTIL DISCHARGE OR DEATH , WHICHEVER IS EARLIER.—

Secondary

MeasureTime frame
ICU admission Need for mechanical ventilation Length of hospital stay Timepoint: AT THE TIME OF ADMISSION AND UPTO 14 DAYS FROM ADMISSION—

Countries

India

Contacts

Public ContactSOUMYADEEP GHOSH

DEPARTMENT OF RESPIRATORY MEDICINE , SANTINIKETAN MEDICAL COLLEGE

SOUMYA.JOTERAM@GMAIL.COM9593754343

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026